IntroductionGleason score (GS) at diagnostic biopsy is an important parameter for therapeutic decision‐making in men with prostate cancer. According to the International Society of Urologic Pathology (ISUP) and World Health Organisation (WHO) guidelines, pathologists should grade each biopsy containing cancer separately, provided that individual cores can be identified, and may also give an overall score for the entire case. However, prostate cancer heterogeneity and multifocality might result in variability of individual biopsy core GS. In such cases it is not evident which GS should be recorded for patient stratification and treatment. For instance, a patient might have one biopsy core presenting with 6 mm GS 3 + 3 = 6 and another biopsy core with 2 mm GS 4 + 3 = 7. In this case, stratification might be based either on the overall GS 3 + 4 = 7 or highest GS 4 + 3 = 7. Discordancy between overall and highest GS particularly affects men with GS 7, as optimal individual therapeutic strategies are not well defined in this subgroup. Studies on overall and highest GS show conflicting results, and have not focused on GS 3 + 4 = 7 in particular. We aimed to compare the clinicopathological characteristics and outcome of men with overall biopsy GS 3 + 4 = 7 with highest GS 3 + 4 = 7 (HI = OV) to those with highest GS > 3 + 4 = 7 (HI > OV).MethodsPatient
Histopathology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera